NO20073909L - Forstover-formulering - Google Patents

Forstover-formulering

Info

Publication number
NO20073909L
NO20073909L NO20073909A NO20073909A NO20073909L NO 20073909 L NO20073909 L NO 20073909L NO 20073909 A NO20073909 A NO 20073909A NO 20073909 A NO20073909 A NO 20073909A NO 20073909 L NO20073909 L NO 20073909L
Authority
NO
Norway
Prior art keywords
nebulized formulation
nebulized
formulation
ipratropium
copd
Prior art date
Application number
NO20073909A
Other languages
English (en)
Inventor
Ian Gardner Cameron Mcaffer
Peter Ernest Tasko
Original Assignee
Breath Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34307728&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20073909(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Breath Ltd filed Critical Breath Ltd
Publication of NO20073909L publication Critical patent/NO20073909L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

En nebulisator-formulering som inneholder levalbuterol og ipratropium i omtrent 2 ml eller mindre saltvann og som anvendes for behandling av COPD og astma og andre luftveissykdommer og lidelser med økt pasient-medgjørlighet.
NO20073909A 2005-01-31 2007-07-25 Forstover-formulering NO20073909L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0501956.7A GB0501956D0 (en) 2005-01-31 2005-01-31 Nebulizer formulation
PCT/GB2006/000309 WO2006079841A1 (en) 2005-01-31 2006-01-30 Nebulizer formulation

Publications (1)

Publication Number Publication Date
NO20073909L true NO20073909L (no) 2007-10-24

Family

ID=34307728

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073909A NO20073909L (no) 2005-01-31 2007-07-25 Forstover-formulering

Country Status (17)

Country Link
US (1) US20080319006A1 (no)
EP (1) EP1843750B1 (no)
JP (1) JP2008528565A (no)
KR (1) KR20070101292A (no)
CN (2) CN102631344A (no)
AU (1) AU2006208880B2 (no)
BR (1) BRPI0606261A2 (no)
CA (1) CA2596215A1 (no)
CZ (1) CZ2007598A3 (no)
ES (1) ES2441733T3 (no)
GB (1) GB0501956D0 (no)
IL (1) IL183578A0 (no)
IS (1) IS8666A (no)
NO (1) NO20073909L (no)
NZ (1) NZ556714A (no)
WO (1) WO2006079841A1 (no)
ZA (1) ZA200704977B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0700380D0 (en) 2007-01-09 2007-02-14 Breath Ltd Storage Of Ampoules
US20100055045A1 (en) 2008-02-26 2010-03-04 William Gerhart Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
US20090215734A1 (en) * 2008-02-26 2009-08-27 Elevation Pharmaceuticals, Inc. Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
CN102166213A (zh) * 2009-11-12 2011-08-31 北京利乐生制药科技有限公司 以左旋沙丁胺醇与异丙托溴铵为活性成分的组合物
EP3297607B1 (en) * 2015-05-18 2020-07-22 Glenmark Specialty S.A. Tiotropium inhalation solution for nebulization
WO2017157265A1 (zh) * 2016-03-15 2017-09-21 广东东阳光药业有限公司 喷雾剂、喷雾装置以及喷雾组件
US20210290568A1 (en) * 2020-03-19 2021-09-23 Cai Gu Huang Inhalable formulation of a solution containing levalbuterol tartrate

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3505337A (en) 1967-12-22 1970-04-07 Boehringer Sohn Ingelheim N - hydrocarbyl-substituted noratropinium,haloalkylates and o-acyl derivatives thereof
JPH0720862B2 (ja) * 1989-01-27 1995-03-08 ヘキスト・アクチエンゲゼルシヤフト 吸入用喘息治療剤
JP2704546B2 (ja) * 1989-04-04 1998-01-26 光利 太良 Ａｔｌｌ治療用吸入剤
US5362755A (en) * 1990-01-05 1994-11-08 Sepracor, Inc. Method for treating asthma using optically pure (R)-albuterol
ES2085468T3 (es) * 1990-01-05 1996-06-01 Sepracor Inc Albuterol r(-) opticamente puro para tratar el asma.
CA2123909C (en) * 1991-12-18 2002-10-01 Christer Carl Gustav Carling New combination of formoterol and budesonide
ES2129117T3 (es) * 1992-12-09 1999-06-01 Boehringer Ingelheim Pharma Formulaciones en disolucion en forma de aerosol medicinales estabilizadas.
US5934272A (en) * 1993-01-29 1999-08-10 Aradigm Corporation Device and method of creating aerosolized mist of respiratory drug
JPH0892098A (ja) * 1994-09-27 1996-04-09 Teijin Ltd 肺結核治療剤
US5603918A (en) * 1995-06-09 1997-02-18 Boehringer Ingelheim Pharmaceuticals, Inc. Aerosol composition of a salt of ipratropium and a salt of albuterol
US6571790B1 (en) * 1997-05-12 2003-06-03 Robert E. Weinstein Method and device for organizing and coordinating the combined use of liquid medications for continuous nebulization for the treatment of respiratory disorders
US7963955B2 (en) * 1998-02-27 2011-06-21 Boehringer Ingelheim International Gmbh Container for a medicinal liquid
US6685691B1 (en) * 1998-02-27 2004-02-03 Boehringer Ingelheim Gmbh Container for a medicinal liquid
GB9807232D0 (en) * 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
NZ509328A (en) * 1998-07-24 2002-11-26 Jago Res A Medicinal aerosol formulations
ATE234604T1 (de) * 1998-08-04 2003-04-15 Jago Res Ag Medizinische aerosolformulierungen
US6261539B1 (en) * 1998-12-10 2001-07-17 Akwete Adjei Medicinal aerosol formulation
US7074388B2 (en) * 1998-12-10 2006-07-11 Kos Life Science, Inc. Water stabilized medicinal aerosol formulation
US6962151B1 (en) * 1999-11-05 2005-11-08 Pari GmbH Spezialisten für effektive Inhalation Inhalation nebulizer
US6451289B2 (en) * 2000-03-24 2002-09-17 Sepracor Inc. Albuterol formulations
GB0012260D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
US20060257324A1 (en) * 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
EE05167B1 (et) * 2000-05-22 2009-06-15 Chiesi Farmaceutici S.P.A. Stabiilsed farmatseutilised lahuspreparaadid survestatud doseerivatele inhalaatoritele
US6667314B2 (en) * 2000-05-26 2003-12-23 Pfizer, Inc. Tropane derivatives useful in therapy
CN100496608C (zh) * 2001-03-30 2009-06-10 洁垢技术有限公司 药用气溶胶制剂
US6667344B2 (en) * 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US6455028B1 (en) * 2001-04-23 2002-09-24 Pharmascience Ipratropium formulation for pulmonary inhalation
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
JP2005508220A (ja) * 2001-10-24 2005-03-31 パーリ・ゲーエムベーハー 薬用組成物調製用具
US20030203930A1 (en) * 2001-10-26 2003-10-30 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
AU3297402A (en) * 2001-10-26 2003-10-30 Dey, L.P. An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US6702997B2 (en) * 2001-10-26 2004-03-09 Dey, L.P. Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
JP2003221335A (ja) * 2001-10-26 2003-08-05 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
US20050175544A1 (en) * 2001-10-26 2005-08-11 Dey Lp Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
US8084461B2 (en) * 2001-10-26 2011-12-27 Dey, L.P. Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US20030191151A1 (en) * 2001-10-26 2003-10-09 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US6974803B2 (en) * 2001-12-06 2005-12-13 Pfizer Inc Pharmaceutical combination
US7084153B2 (en) * 2002-04-12 2006-08-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising steroids and a novel anticholinergic
US20040241103A1 (en) * 2002-09-10 2004-12-02 3M Innovative Properties Company Pharmaceutical aerosol compositions
EP1417958A1 (en) * 2002-11-08 2004-05-12 Pari GmbH Wet granulation process
US7550133B2 (en) * 2002-11-26 2009-06-23 Alexza Pharmaceuticals, Inc. Respiratory drug condensation aerosols and methods of making and using them
PL378753A1 (pl) * 2003-02-27 2006-05-15 F.Hoffmann-La Roche Ag Antagoniści receptora CCR-3
ES2304616T3 (es) * 2003-03-20 2008-10-16 Boehringer Ingelheim Pharmaceuticals Inc. Formulacion para un inhalador con dosis medida utilizando hidro-fluoro-alcanos como propulsores.
EP1610788A1 (en) * 2003-03-28 2006-01-04 ALTANA Pharma AG Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
US20060251711A1 (en) * 2003-08-28 2006-11-09 Vgsk Technologies, Inc. Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating diseases of the respiratory tract of a mammal
DE10347994A1 (de) * 2003-10-15 2005-06-16 Pari GmbH Spezialisten für effektive Inhalation Wässrige Aerosol-Zubereitung
US9308199B2 (en) * 2004-04-29 2016-04-12 Honeywell International Inc. Medicament formulations
WO2005044187A2 (en) * 2003-10-28 2005-05-19 Glaxo Group Limited Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
WO2005077339A1 (en) * 2004-02-10 2005-08-25 E.I. Dupont De Nemours And Company Process for preparing stable sol of pharmaceutical ingredients and hydrofluorocarbon comprising milling the said sol, then transfert it into a canister
TWI341836B (en) * 2004-03-11 2011-05-11 Theravance Inc Biphenyl compounds useful as muscarinic receptor antagonists
US7262205B2 (en) * 2004-03-11 2007-08-28 Theravance, Inc. Biphenyl compounds useful as muscarinic receptor antagonists
EP1776076A2 (en) * 2004-06-08 2007-04-25 Robert E. Coifman Ampules for small unit dose volumes of drug
BRPI0512878A (pt) * 2004-07-02 2008-04-15 Boehringer Ingelheim Int formulações de suspensão de aerossol, com tg 227 ea ou tg 134 a como agente propulsor
EP1785421A1 (en) * 2004-08-30 2007-05-16 Ono Pharmaceutical Co., Ltd. Tropan compound
EA200700600A1 (ru) * 2004-09-09 2008-02-28 Сипла Лимитед Фармацевтическая композиция, содержащая изомер бета-миметического агента и антихолинергический агент
GB0422413D0 (en) * 2004-10-08 2004-11-10 Breath Ltd High efficiency nebulisation
AU2004325349A1 (en) * 2004-12-03 2006-06-08 Thirumalai Anandampilai Anandvishnu A resonating (alerting) metered dose inhaler
US20060120967A1 (en) * 2004-12-07 2006-06-08 Qpharma, Llc Solution forms of cyclodextrins for nasal or throat delivery of essential oils
FR2879574B1 (fr) * 2004-12-17 2011-01-21 Valois Sas Dispositif de distribution de produit fluide.
RU2440972C2 (ru) * 2004-12-17 2012-01-27 Сипла Лимитед Кристаллический сульфат левосальбутамола, способ его получения и фармацевтическая композиция, содержащая его
US20060140873A1 (en) * 2004-12-27 2006-06-29 Chang Heng W Aerosol pharmaceutical compositions
JP2008542332A (ja) * 2005-05-31 2008-11-27 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 呼吸器疾患治療用新規医薬組成物
WO2007020204A2 (en) * 2005-08-12 2007-02-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Hfc solution formulations for inhalation containing salbutamol hydrochloride or salbutamol citrate
US20070293460A1 (en) * 2005-10-31 2007-12-20 Richie's Pharmacy And Medical Supply, Incorporated Delivery of a combination therapy for asthma and chronic obstructive pulmonary disease
JP2009526063A (ja) * 2006-02-09 2009-07-16 シェーリング コーポレイション 医薬製剤
GB0604141D0 (en) * 2006-03-01 2006-04-12 Arrow Int Ltd Nebulizer formulation

Also Published As

Publication number Publication date
CZ2007598A3 (cs) 2007-10-17
IL183578A0 (en) 2009-02-11
WO2006079841A1 (en) 2006-08-03
US20080319006A1 (en) 2008-12-25
BRPI0606261A2 (pt) 2009-06-13
AU2006208880B2 (en) 2010-08-26
EP1843750B1 (en) 2013-10-16
CA2596215A1 (en) 2006-08-03
ZA200704977B (en) 2008-11-26
JP2008528565A (ja) 2008-07-31
ES2441733T3 (es) 2014-02-06
CN101090709A (zh) 2007-12-19
NZ556714A (en) 2009-12-24
IS8666A (is) 2007-08-02
GB0501956D0 (en) 2005-03-09
AU2006208880A1 (en) 2006-08-03
KR20070101292A (ko) 2007-10-16
EP1843750A1 (en) 2007-10-17
CN102631344A (zh) 2012-08-15

Similar Documents

Publication Publication Date Title
NO20083683L (no) Nebulisatorformulering
NO20072920L (no) Kombinasjon av metylxantinforbindelser og steroider for a behandle kroniske respirasjonssykdommer
NO20075287L (no) Kombinasjon av antikolinergika og leukotnen-reseptorantagonister for behandling av andedrettslidelser
MEP30108A (en) Formoterol superfine formulation
ATE330589T1 (de) Pharmazeutische zusammensetzung enthaltend resveratrol zur behandlung von entzündlichen erkrankungen der atemwege
CY1106430T1 (el) Φαρμακα για εισπνοη που πepιλαμβανουν βηταμιμητικα και αντιχολινepγικο
SG158120A1 (en) Respiratory devices and methods of use
ECSP055855A (es) Medicamentos en polvo para inhalación que contiene una sal de tiotropio y salmeterolxinafoato
DE602005026007D1 (de) Opioide zur behandlung von chronisch-obstruktiver lungenerkrankung (copd)
NO20044107L (no) Medikamenter inneholdende betamimetica og et nytt anticholinergisk legemiddel
UA100777C2 (ru) Вдыхаемые частички, содержащие тиотропий
MY146628A (en) Novel crystalline anhydride with anticholinergic effect
CY1114157T1 (el) Αλατα του τιοτροπιου, μεθοδος για την παραγωγη τους και φαρμακευτικα σκευασματα που τα περιεχουν
NO20063047L (no) Vandige ciclesonidsuspensjoner for forstoving
NO20081480L (no) Kombinasjon av forbindelser som kan brukes ved behandling av respiratoriske sykdommer, spesielt kronisk obstruktiv pulmonaer sykdom (COPD) og astma
CN204364587U (zh) 雾化器桌面支架
NO20061441L (no) Nye tiotropiumsalter, metoder for deres fremstilling, og farmasoytiske formuleringer inneholdende disse
HRP20050224B1 (hr) Kombinacija loteprednol etabonata i dfho za liječenje bolesti dišnih putova, alergijskih bolesti, astme i kronične opstruktivne plućne bolesti (copd)
BRPI0606261A2 (pt) formulação de nebulizador
NO20053090L (no) Pulverformulering for innhalering inneholdende tiotropium.
EA200701077A1 (ru) Применение конъюгатов липидов при лечении заболеваний
MXPA04007294A (es) Composicion para inhalacion.
BR112019007259A2 (pt) recipiente de câmara dupla adequado para uso com um nebulizador e pré-carregado com uma composição nebulizável, kit, composição nebulizável, solução nebulizável aquosa, método para administrar de tiotrópio e formoterol a um paciente com necessidade do mesmo e método para preparar um nebulizador
MX2010003618A (es) Lisina de aztreonam inhalada para el tratamiento de deficits en la calidad de vida relacionada con la salud en enfermedades pulmonares.
CN205084136U (zh) 一种医用雾化器支架

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application